Moxifloxacin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00218 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperamylasemia | KG + DL |
| 2 | polyclonal hyperviscosity syndrome | KG + DL |
| 3 | congenital analbuminemia | KG + DL |
| 4 | blood group incompatibility | KG + DL |
| 5 | premalignant hematological system disease | KG + DL |
| 6 | monoclonal gammopathy | KG + DL |
| 7 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 8 | congenital hematological disorder | KG + DL |
| 9 | hematopoietic and lymphoid system neoplasm | KG + DL |
| 10 | bubonic plague | KG + DL |
| 11 | endomyometritis | KG + DL |
| 12 | bronchitis | KG + DL |
| 13 | urinary tract infection (disease) | KG + DL |
| 14 | gonococcal urethritis | KG + DL |
| 15 | Ureaplasma urethritis | KG + DL |
| 16 | pyelitis | KG + DL |
| 17 | uterine inflammatory disease | KG + DL |
| 18 | pyelonephritis | KG + DL |
| 19 | xanthogranulomatous pyelonephritis | KG + DL |
| 20 | chronic tubotympanic suppurative otitis media | KG + DL |
| 21 | cystitis | KG + DL |
| 22 | L-ferritin deficiency | KG + DL |
| 23 | acute gonococcal cystitis | KG + DL |
| 24 | laryngotracheitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.